Recently Funded Projects
Explore the research projects funded by SRUK
Find out more
SRUK fund vital, innovative research into the causes, progression, and treatment of both Scleroderma and Raynaud’s. We have invested over £12 million since the formation of SRUK’s two founding charities.
SRUK are the only UK charity funding medical research into Raynaud’s and Scleroderma. The research we support results in vital discoveries of new treatments and therapies, and helps to evolve of our understanding of the causation and progression of both conditions. Since SRUK’s formation in 2016 we have invested over £2 million in research aligning to the 4 priority areas identified by our community and clinical experts; precision medicine, early detection and diagnosis, quality of life, and causes, as established in our research strategy.
To find out more about the pioneering research projects that your money is helping to support, visit the pages below.
Read on to find out more information about upcoming SRUK research initiatives that you can take part in, including community surveys and focus groups.
SRUK Patient Registry Survey
Follow this link to access our SRUK Patient Registry Survey, to share your views and help shape an exciting upcoming project which aims to support research and improve outcomes for those living with Scleroderma and Raynaud’s: https://www.surveymonkey.co.uk/r/8NH8Z9N
Children & Young People Online Meet-Up
If you have scleroderma and are aged between 12 and 21, join us for an exciting new focus group on November 27th 2023 at 6pm to learn more about SRUK, and help support research and improve care for people like you! Click here to register, or scan the QR code on the flyer below.
Parents & Carers Online Meet-Up
If you care for a child or young person with scleroderma, we’d love for you to attend our online meet-up on December 4th 2023 at 6pm to learn more about SRUK and share your views on our exciting new project which aims to help support research and improve care for young people living with the condition. Click here to register, or scan the QR code on the flyer below.
The Raynaud’s and Scleroderma Association (RSA) and the Scleroderma Society (SS) merged in 2016 to become SRUK, having being founded separately in 1982. Both had a rich history of providing excellent support services to the community and investing in research to improve the knowledge and understanding of these conditions. Between them, they funded over £10 million in research – leading to many breakthroughs which are highlighted in our Impact Report.
SRUK’s research policy is guided by both our Research Strategy, and the Association of Medical Research Charities (AMRC) of which we are a proud member.
Our statement on the use of animals in research.